These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

591 related items for PubMed ID: 12857909

  • 1. Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.
    Hornemann S, Harlin O, Staib C, Kisling S, Erfle V, Kaspers B, Häcker G, Sutter G.
    J Virol; 2003 Aug; 77(15):8394-407. PubMed ID: 12857909
    [Abstract] [Full Text] [Related]

  • 2. Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes.
    Ludwig H, Mages J, Staib C, Lehmann MH, Lang R, Sutter G.
    J Virol; 2005 Feb; 79(4):2584-96. PubMed ID: 15681458
    [Abstract] [Full Text] [Related]

  • 3. Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line.
    Carroll MW, Moss B.
    Virology; 1997 Nov 24; 238(2):198-211. PubMed ID: 9400593
    [Abstract] [Full Text] [Related]

  • 4. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
    Volz A, Jany S, Freudenstein A, Lantermann M, Ludwig H, Sutter G.
    Viruses; 2018 Jan 04; 10(1):. PubMed ID: 29300297
    [Abstract] [Full Text] [Related]

  • 5. Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells.
    Peng C, Moss B.
    Proc Natl Acad Sci U S A; 2020 Feb 18; 117(7):3759-3767. PubMed ID: 32019881
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modified vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and acts together with the early viral protein E3L to block virus-associated apoptosis.
    Fischer SF, Ludwig H, Holzapfel J, Kvansakul M, Chen L, Huang DC, Sutter G, Knese M, Häcker G.
    Cell Death Differ; 2006 Jan 18; 13(1):109-18. PubMed ID: 16003387
    [Abstract] [Full Text] [Related]

  • 8. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.
    Sutter G, Ramsey-Ewing A, Rosales R, Moss B.
    J Virol; 1994 Jul 18; 68(7):4109-16. PubMed ID: 8207789
    [Abstract] [Full Text] [Related]

  • 9. Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice.
    Meisinger-Henschel C, Späth M, Lukassen S, Wolferstätter M, Kachelriess H, Baur K, Dirmeier U, Wagner M, Chaplin P, Suter M, Hausmann J.
    J Virol; 2010 Oct 18; 84(19):9907-19. PubMed ID: 20668072
    [Abstract] [Full Text] [Related]

  • 10. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.
    Drexler I, Heller K, Wahren B, Erfle V, Sutter G.
    J Gen Virol; 1998 Feb 18; 79 ( Pt 2)():347-52. PubMed ID: 9472619
    [Abstract] [Full Text] [Related]

  • 11. Loss of protein kinase PKR expression in human HeLa cells complements the vaccinia virus E3L deletion mutant phenotype by restoration of viral protein synthesis.
    Zhang P, Jacobs BL, Samuel CE.
    J Virol; 2008 Jan 18; 82(2):840-8. PubMed ID: 17959656
    [Abstract] [Full Text] [Related]

  • 12. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
    Waibler Z, Anzaghe M, Ludwig H, Akira S, Weiss S, Sutter G, Kalinke U.
    J Virol; 2007 Nov 18; 81(22):12102-10. PubMed ID: 17855554
    [Abstract] [Full Text] [Related]

  • 13. Antagonizing activity of vaccinia virus E3L against human interferons in Huh7 cells.
    Arsenio J, Deschambault Y, Cao J.
    Virology; 2008 Jul 20; 377(1):124-32. PubMed ID: 18502465
    [Abstract] [Full Text] [Related]

  • 14. Functional F11L and K1L genes in modified vaccinia virus Ankara restore virus-induced cell motility but not growth in human and murine cells.
    Zwilling J, Sliva K, Schwantes A, Schnierle B, Sutter G.
    Virology; 2010 Sep 01; 404(2):231-9. PubMed ID: 20627347
    [Abstract] [Full Text] [Related]

  • 15. Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells.
    Erez N, Wyatt LS, Americo JL, Xiao W, Moss B.
    J Virol; 2021 Sep 09; 95(19):e0110421. PubMed ID: 34232734
    [Abstract] [Full Text] [Related]

  • 16. Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara.
    Meisinger-Henschel C, Schmidt M, Lukassen S, Linke B, Krause L, Konietzny S, Goesmann A, Howley P, Chaplin P, Suter M, Hausmann J.
    J Gen Virol; 2007 Dec 09; 88(Pt 12):3249-3259. PubMed ID: 18024893
    [Abstract] [Full Text] [Related]

  • 17. Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.
    Chahroudi A, Garber DA, Reeves P, Liu L, Kalman D, Feinberg MB.
    J Virol; 2006 Sep 09; 80(17):8469-81. PubMed ID: 16912297
    [Abstract] [Full Text] [Related]

  • 18. Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses.
    Wolferstätter M, Schweneker M, Späth M, Lukassen S, Klingenberg M, Brinkmann K, Wielert U, Lauterbach H, Hochrein H, Chaplin P, Suter M, Hausmann J.
    J Virol; 2014 Dec 09; 88(24):14396-411. PubMed ID: 25297997
    [Abstract] [Full Text] [Related]

  • 19. Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components.
    Waibler Z, Anzaghe M, Frenz T, Schwantes A, Pöhlmann C, Ludwig H, Palomo-Otero M, Alcamí A, Sutter G, Kalinke U.
    J Virol; 2009 Feb 09; 83(4):1563-71. PubMed ID: 19073732
    [Abstract] [Full Text] [Related]

  • 20. Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells.
    Deng L, Dai P, Ding W, Granstein RD, Shuman S.
    J Virol; 2006 Oct 09; 80(20):9977-87. PubMed ID: 17005676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.